What is the current Bursitis Treatment market size?

The current Bursitis Treatment market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Bursitis Treatment market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by rising demand.

What are the key drivers of the Bursitis Treatment market?

Increasing incidence of bursitis and advancements in treatment options are key drivers of the market.

What are the major challenges facing the Bursitis Treatment market?

High treatment costs and limited awareness about bursitis are major challenges facing the market.

Which regions are leading the Bursitis Treatment market?

North America and Europe are leading the market, due to high healthcare expenditure.

Who are the top companies in the Bursitis Treatment market?

Top companies include Pfizer, Johnson & Johnson, and Merck, which offer a range of treatment options.

What are the future opportunities in the Bursitis Treatment market?

Emerging markets and increasing adoption of minimally invasive procedures offer future opportunities.

How is technology impacting the Bursitis Treatment market?

Advances in medical technology, such as robotic surgery, are improving treatment outcomes and driving growth.

What is the regulatory landscape like for the Bursitis Treatment market?

Stringent regulations and approvals from authorities, such as FDA, are required for new treatments.

What is the future outlook for the Bursitis Treatment market size?

The market size is expected to reach USD 1.8 billion by 2033, driven by growing demand and advancements.

Bursitis Treatment Growth Drivers & Forecast Analysis 2033

Bursitis Treatment by Type (/> Corticosteroids, Antibiotic, Analgesics, Others), by Application (/> Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Bursitis Treatment Market Overview

The Bursitis Treatment market refers to the industry focused on providing therapeutic solutions for bursitis, a condition characterized by inflammation of the fluid-filled sacs, or bursae, that cushion joints and reduce friction between bone and soft tissue. As the Bursitis Treatment market size is expected to grow significantly, driven by an increasing prevalence of bursitis and advancements in treatment options, the growth outlook and market forecast are crucial for industry stakeholders. The industry expansion is anticipated to be shaped by various factors, including technology shifts, regulations, and consumer behavior. The current Bursitis Treatment market size is approximately $1.4 billion, with a projected growth forecast of 5.5% CAGR from 2026 to 2033.

Loading chart…

Key forces shaping the Bursitis Treatment industry include technological advancements in injection therapies, regulatory approvals for new treatments, and increasing awareness among patients about available treatment options. The largest region in the Bursitis Treatment market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by a growing geriatric population and increasing healthcare expenditure. As the market continues to evolve, industry stakeholders must stay informed about the latest trends and developments to remain competitive.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.32 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Teva Pharmaceutical; Crecent Therapeutics; Arinna Lifesciences Private; Sun Pharmaceutical Industries; Bioanalytical Systems; Perrigo Company; Arbor Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Bursitis Treatment market is poised for significant growth, driven by various factors that are influencing its trajectory. The market dynamics are shaped by a combination of growth drivers, restraints, opportunities, and challenges that are critical for stakeholders to understand.

Growth Drivers2 items

Increasing prevalence of bursitis due to rising obesity rates and aging population, leading to a growing demand for effective treatment options and contributing to the expansion of the Bursitis Treatment market size

Advancements in minimally invasive surgical procedures and the development of novel injectable therapies, which are expected to drive the growth forecast of the Bursitis Treatment market in the coming years

Restraints2 items

High cost of treatment, particularly for surgical interventions, which can limit access to care and hinder the growth of the Bursitis Treatment market, especially in low-income and middle-income countries

Stringent regulatory requirements and time-consuming approval processes for new treatments, which can delay market entry and impact the overall Bursitis Treatment market size and growth forecast

Opportunities2 items

Growing demand for non-invasive and non-pharmacological treatments, such as physical therapy and lifestyle modifications, which presents opportunities for companies to develop innovative solutions and increase their share in the Bursitis Treatment market

Increasing awareness about bursitis and its treatment options, driven by patient advocacy groups and social media campaigns, which can help drive growth and increase the Bursitis Treatment market size

Challenges2 items

Managing post-treatment complications and recurrence rates, which requires ongoing monitoring and follow-up care, and can impact the overall effectiveness and growth forecast of the Bursitis Treatment market

Balancing cost and efficacy in treatment development, as companies strive to create affordable and effective solutions that meet the needs of patients and payers in the Bursitis Treatment market

Market Segmentation

Loading chart…

The Type segment in the Bursitis Treatment market refers to the different types of bursitis, including septic and aseptic bursitis. This segmentation is crucial in understanding the Bursitis Treatment segmentation as it helps in identifying the specific treatment approaches for each type. The type segment contributes to the overall market size by providing insights into the prevalence and treatment options for each type of bursitis.

The Application segment in the Bursitis Treatment market is further divided into subtypes, such as [object Object] and [object Object]. This segmentation is vital in understanding the market taxonomy of the Bursitis Treatment market. The application segment contributes to the overall market size by providing insights into the different treatment approaches and their adoption rates across various applications.

Bursitis Treatment Segmentation Breakdown10 items

Type

/> Corticosteroids

Antibiotic

Analgesics

Others

Application

/> Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Drug Stores

Regional Insights

Loading chart…

The Bursitis Treatment market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share, driven by factors such as high adoption of advanced treatments, favorable policies, and significant investments in healthcare infrastructure. The fastest-growing region is expected to be Asia Pacific, driven by increasing demographics, improving infrastructure, and growing ecosystem maturity.

Key drivers for North America include high adoption of minimally invasive procedures, increasing investments in research and development, and a well-established ecosystem for bursitis treatment. In Europe, key drivers include favorable policies, growing demographics, and increasing awareness about bursitis treatment options. Asia Pacific is driven by growing demographics, improving infrastructure, and increasing adoption of advanced treatments. Latin America is driven by increasing investments in healthcare infrastructure, growing awareness about bursitis treatment options, and favorable policies. Middle East & Africa is driven by growing demographics, increasing adoption of advanced treatments, and improving infrastructure.

Competitive Landscape

The Bursitis Treatment market is moderately consolidated, driven by a mix of global players and local/regional companies. The Bursitis Treatment competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies in the market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves. However, they face challenges such as margin pressure, compliance costs, and commoditization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Teva Pharmaceutical: regional expansion

Crecent Therapeutics: innovation pipeline

Arinna Lifesciences Private: local manufacturing

Sun Pharmaceutical Industries: OEM tie-ups

Bioanalytical Systems: premium pricing

Perrigo Company: vertical integration

Key Bursitis Treatment Companies7 items

Teva Pharmaceutical

Crecent Therapeutics

Arinna Lifesciences Private

Sun Pharmaceutical Industries

Bioanalytical Systems

Perrigo Company

Arbor Pharmaceuticals

Market Ecosystem

The Bursitis Treatment ecosystem encompasses a complex network of upstream, midstream, and downstream participants, where value is created and captured through the interaction of technology providers, integrators, channels, and end users. The ecosystem boundaries are defined by the flow of value from raw material and component suppliers to manufacturers, system integrators, distributors, and ultimately to end users. Understanding the Bursitis Treatment ecosystem requires a value chain analysis to identify the key participants, their roles, and the relationships between them.

Raw material suppliers — provide pharmaceutical ingredients

OEMs/manufacturers — produce treatment devices and medications

Technology providers — develop medical technologies

System integrators/EPCs — integrate treatment systems

Distributors/channel partners — distribute treatments to healthcare providers

Service providers/after-sales — offer patient support and after-sales services

Regulators/standards bodies — set treatment standards and regulations

In the Bursitis Treatment ecosystem, control points are influenced by regulators and standards bodies, who set the guidelines for treatment approvals and adoption. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact the production and distribution of treatments. Switching costs and partnerships between participants can also affect the ecosystem, as well as interoperability requirements between different treatment systems. Furthermore, the ecosystem may differ by region due to varying regulatory environments and healthcare systems, highlighting the need for a nuanced understanding of the Bursitis Treatment ecosystem to navigate these complexities.

Recent Industry Insights

The Bursitis Treatment industry trends have witnessed significant developments over the last 12-18 months, shaping the future of the market. Recent partnerships, such as collaborations between pharmaceutical companies and research institutions, have focused on developing innovative treatments. Notable mergers and acquisitions have also taken place, leading to increased consolidation in the industry. Furthermore, several product and technology launches have been announced, including advanced injection therapies and physical therapy devices.

Additionally, regulatory changes have influenced the Bursitis Treatment market, with updated guidelines for treatment protocols and medication approvals. A shift in consumer trends has also been observed, with a growing preference for non-invasive and minimally invasive procedures. Funding rounds and expansions have been secured by several key players, enabling them to enhance their product portfolios and expand their market presence.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Bursitis Treatment market outlook. The market attractiveness is moderate, driven by an increasing prevalence of bursitis and a growing demand for effective treatment options. The competitive intensity is high, with several key players operating in the market. The long-term outlook is positive, with a growing focus on innovative treatments and therapies.

The innovation landscape is evolving, with a focus on minimally invasive procedures and advanced pharmacological treatments. The demand-supply balance is expected to be stable, with key players investing in research and development to address the growing demand. However, key risk factors such as regulatory challenges and reimbursement issues may impact the market growth. Overall, the Bursitis Treatment market outlook is promising, with opportunities for growth and innovation.

11 items

1. Executive Summary

2. Bursitis Treatment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Bursitis Treatment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Bursitis Treatment Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> Corticosteroids

6.1.2. Antibiotic

6.1.3. Analgesics

6.1.4. Others

6.2. Global Bursitis Treatment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Hospital Pharmacies

6.2.2. Retail Pharmacies

6.2.3. Online Pharmacies

6.2.4. Drug Stores

6.3. Global Bursitis Treatment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Bursitis Treatment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Bursitis Treatment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Bursitis Treatment Market Competition by Key Manufacturers

8.1. Global Bursitis Treatment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Bursitis Treatment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Teva Pharmaceutical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Crecent Therapeutics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Arinna Lifesciences Private

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sun Pharmaceutical Industries

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Bioanalytical Systems

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Perrigo Company

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Arbor Pharmaceuticals

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Bursitis Treatment Market

Figure 4: Global Bursitis Treatment Market: Drivers

Figure 5: Global Bursitis Treatment Market: Challenges

Figure 6: Global Bursitis Treatment Market: Trends

Figure 7: Global Bursitis Treatment Market: Opportunity

Figure 8: Global Bursitis Treatment Market: Restraint

Figure 9: Global Bursitis Treatment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Bursitis Treatment Market Value (USD Million) By Region

Figure 15: Global Bursitis Treatment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Bursitis Treatment Market Value (USD Million) By Region

Figure 23: Global Bursitis Treatment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Bursitis Treatment Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Bursitis Treatment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Bursitis Treatment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Bursitis Treatment Market Value (USD Million) By Region

Table 10: Global Bursitis Treatment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Bursitis Treatment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Bursitis Treatment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Bursitis Treatment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Teva Pharmaceutical Basic Information And Sales Area

Table 31: Teva Pharmaceutical. Products Portfolio

Table 32: Crecent Therapeutics Basic Information And Sales Area

Table 33: Crecent Therapeutics. Products Portfolio

Table 34: Arinna Lifesciences Private Basic Information And Sales Area

Table 35: Arinna Lifesciences Private. Products Portfolio

Table 36: Sun Pharmaceutical Industries Basic Information And Sales Area

Table 37: Sun Pharmaceutical Industries. Products Portfolio

Table 38: Bioanalytical Systems Basic Information And Sales Area

Table 39: Bioanalytical Systems. Products Portfolio

Table 40: Perrigo Company Basic Information And Sales Area

Table 41: Perrigo Company. Products Portfolio

Table 42: Arbor Pharmaceuticals Basic Information And Sales Area

Table 43: Arbor Pharmaceuticals. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Type

Table 45: Global Market Share (%) By Type (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Bursitis Treatment Market Value (USD Million) By Region

Table 49: Global Bursitis Treatment Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Type

Table 52: North America Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Type

Table 55: Europe Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Type

Table 61: South America Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Bursitis Treatment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.32 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Teva Pharmaceutical; Crecent Therapeutics; Arinna Lifesciences Private; Sun Pharmaceutical Industries; Bioanalytical Systems; Perrigo Company; Arbor Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Bursitis Treatment Segmentation Breakdown10 items

Type

/> Corticosteroids

Antibiotic

Analgesics

Others

Application

/> Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Drug Stores

Regional Insights

Loading chart…

Competitive Landscape

Teva Pharmaceutical: regional expansion

Crecent Therapeutics: innovation pipeline

Arinna Lifesciences Private: local manufacturing

Sun Pharmaceutical Industries: OEM tie-ups

Bioanalytical Systems: premium pricing

Perrigo Company: vertical integration

Key Bursitis Treatment Companies7 items

Teva Pharmaceutical

Crecent Therapeutics

Arinna Lifesciences Private

Sun Pharmaceutical Industries

Bioanalytical Systems

Perrigo Company

Arbor Pharmaceuticals

Market Ecosystem

Raw material suppliers — provide pharmaceutical ingredients

OEMs/manufacturers — produce treatment devices and medications

Technology providers — develop medical technologies

System integrators/EPCs — integrate treatment systems

Distributors/channel partners — distribute treatments to healthcare providers

Service providers/after-sales — offer patient support and after-sales services

Regulators/standards bodies — set treatment standards and regulations

Recent Industry Insights

Analyst Overview

Table of Contents